Cargando…

Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the third leading cause of cancer-related death worldwide. Factors including carcinogens, infection of hepatitis viruses, alcohol abuse, and metabolic disorders such as non-alcoholic fatty liver disease mainly contribute to H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chun-Ye, Liu, Shuai, Yang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516657/ https://www.ncbi.nlm.nih.gov/pubmed/36187392 http://dx.doi.org/10.4251/wjgo.v14.i9.1887

Ejemplares similares

Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma
por: Yamada, Tomoharu, et al.
Publicado: (2023)

Intrinsic PD‐L1 promotes antitumor activity of CD8(+) cytotoxic T lymphocytes via in cis interaction with CD80
por: Ding, Yuming, et al.
Publicado: (2022)

Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection
por: Khan, Fahad, et al.
Publicado: (2020)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021)

What clinicopathological factors affect the recurrence of hepatocellular carcinoma after surgery?
por: Deng, Min, et al.
Publicado: (2022)

PMN‐MDSCs‐induced accumulation of CD8+CD39+ T cells predicts the efficacy of chemotherapy in esophageal squamous cell carcinoma
por: Qin, Guohui, et al.
Publicado: (2020)

Identification of IRF8 as an immune infiltration‐related biomarker in hepatocellular carcinoma by bioinformatics analysis
por: Zhang, Renyu, et al.
Publicado: (2022)

Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study
por: Huang, Cheng, et al.
Publicado: (2022)

Simple method for predicting muscle volume loss using geriatric nutritional risk index in hepatocellular carcinoma patients
por: Hiraoka, Atsushi, et al.
Publicado: (2023)

CD4+CD8+ Double-Positive T-Lymphocytes: Pitfalls
por: Yavaşoğlu, İrfan
Publicado: (2020)

Octreotide and hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2007)

Glutamine deprivation impairs function of infiltrating CD8(+ )T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis
por: Wang, Wei, et al.
Publicado: (2022)

In Reply to: CD4+CD8+ Double-Positive T-Lymphocytes: Pitfalls
por: Gonzalez-Mancera, Miguel Santiago, et al.
Publicado: (2020)

Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19
por: O'Callaghan, M.E., et al.
Publicado: (2020)

PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
por: Yang, Xiao-Dong, et al.
Publicado: (2021)

Megestrol treatment in patients with hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2001)

Drug-eluting beads in hepatocellular carcinoma
por: Abe, Hiroyuki, et al.
Publicado: (2017)

Hepatocellular carcinoma biomarkers, an imminent need
por: Zamora-León, S Pilar
Publicado: (2021)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2023)

T-cell prolymphocytic leukaemia: spontaneous immunophenotypical switch from CD4 to CD8 expression
por: Tse, Eric, et al.
Publicado: (2010)

Serum exosomal long noncoding RNA CRNDE level for hepatocellular carcinoma diagnosis
por: Huang, Xiao‐Li, et al.
Publicado: (2021)

Long‐term antibiotic use and risk of hepatocellular carcinoma later in life: a nationwide cohort study of 9.8 million participants
por: Jeong, Seogsong, et al.
Publicado: (2023)

Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid
por: Lee, Joon, et al.
Publicado: (2015)

Revision and addendum to the manuscript titled “Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma”
por: Wang, Wei, et al.
Publicado: (2023)

Unusual association of CD8+ T-cell lymphocytosis with invasive thymoma
por: Huh, Hee Jin, et al.
Publicado: (2015)

Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
por: Park, Jeong Su, et al.
Publicado: (2020)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma
por: Zhang, Zhihui, et al.
Publicado: (2021)

Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance
por: Wang, Yulei, et al.
Publicado: (2021)

FMO4 shapes immuno‐metabolic reconfiguration in hepatocellular carcinoma
por: Luo, Yan, et al.
Publicado: (2022)

Evidence for CD19B–CD8T cell interactions in blood and tissues from patients with GvHD
por: Deola, S, et al.
Publicado: (2017)

Effect of Lactate on Epigenetic Regulation in the Development of Hepatitis B Virus-related Hepatocellular Carcinoma
por: Mahmoudvand, Shahab, et al.
Publicado: (2022)

Linking peripheral CD8(+) single‐cell transcriptomic characteristics of mood disorders underlying with the pathological mechanism
por: Lu, Jing, et al.
Publicado: (2021)

The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma
por: Li, Zhixuan, et al.
Publicado: (2020)

Reply: Prostate cancer, insulin and androgen deprivation therapy
por: Lehrer, S
Publicado: (2003)

Androgen deprivation therapy in high risk prostate cancer
por: Van Dams, Ritchell, et al.
Publicado: (2019)

Portal vein embolization, biembolization, and liver venous deprivation
por: Luz, José Hugo Mendes, et al.
Publicado: (2021)

Risk Factors and Incidence of Hepatocellular Carcinoma in Southeast Iran
por: Saiedi Hosseini, Seyed Yasser
Publicado: (2011)

Hepatocellular carcinoma hidden by multiple infarcted regenerative nodules
por: Kim, Jin Ah, et al.
Publicado: (2016)

Rare Case of Hepatocellular Carcinoma Invading the Right Atrium
por: Alhawassi, Sami
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ov2qbbqiibsiui6e0v0ptbkqsn